GI
BMRN icon

GLG Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History

GLG Inc’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$1.12M Sell
15,913
-19,750
-55% -$1.34M 0.03% 478
2013
Q3 		$2.58M Buy
35,663
+28,935
+430% +$1.92M 0.05% 378
2013
Q2 		$375K Buy
+6,728
New +$419K 0.01% 596

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GLG Inc's BMRN Position: Q4 2013 in Review

GLG Inc reduced its BioMarin Pharmaceuticals (BMRN) stake by 55% in Q4 2013, selling an estimated $1.34M and leaving 15,913 shares worth $1.12M. The position accounts for 0.03% of the portfolio, ranked #478.

GLG Inc first reported a position in BMRN in Q2 2013 and has held it in 3 quarters since. The position peaked at $2.58M in Q3 2013. 306 funds tracked by Wall St. Rank hold BMRN as of Q4 2013.

  • GLG Inc held 15,913 shares of BioMarin Pharmaceuticals worth $1.12M as of Q4 2013.
  • GLG Inc sold 19,750 BioMarin Pharmaceuticals shares in Q4 2013, an estimated $1.34M.
  • BioMarin Pharmaceuticals made up 0.03% of GLG Inc's portfolio in Q4 2013, its #478 holding.
  • GLG Inc first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
  • GLG Inc's BioMarin Pharmaceuticals position peaked at $2.58M in Q3 2013.
  • 306 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.